Clinical Trial

The Effectiveness and Safety of Dupilumab in Children with Asthma in China: a Real-world Study

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated February 28, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Observe the changes of type II inflammation markers, lung function, and symptom scores in asthmatic patients aged 6 to 14 during the use of dupilumab to analyze its efficacy.
Trial Details
NCT Number NCT06851403
Lead Sponsor Guangzhou Institute of Respiratory Disease
Conditions Asthma in Children
Enrollment 213 participants
Start Date 2022-01-30
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-28